Table 2.
Correlation of Gli1 expression with cancer stem cell maker expression in prostate cancer
| Variable | N | Gli1 (-) n (%) | Gli1 (+) n (%) | χ2 | R | P-value |
|---|---|---|---|---|---|---|
| Sox2 | 0.000 | 0.001 | 0.989 | |||
| Negative | 43 | 20 (46.5) | 23 (53.5) | |||
| Positive | 102 | 50 (49.0) | 52 (51.0) | |||
| Sox9 | 1.721 | 0.111 | 0.190 | |||
| Negative | 8 | 2 (25.0) | 6 (75.0) | |||
| Positive | 137 | 68 (49.6) | 69 (50.4) | |||
| LSD1 | 0.002 | 0.004 | 0.968 | |||
| Negative | 21 | 10 (47.6) | 11 (52.4) | |||
| Positive | 124 | 60 (48.4) | 64 (51.6) | |||
| CD44 | 17.363 | 0.356 | <0.001* | |||
| Negative | 34 | 27 (79.4) | 7 (20.6) | |||
| Positive | 111 | 43 (38.7) | 68 (61.3) |
*
Statistically significant.